![]() |
市场调查报告书
商品编码
1800962
气道正压通气设备市场报告(按产品类型(自动气道正压通气设备、持续性气道正压通气设备、双水平气道正压通气设备)、最终用户和地区,2025 年至 2033 年)Positive Airway Pressure Devices Market Report by Product Type (Automatic Positive Airway Pressure Devices, Continuous Positive Airway Pressure Devices, Bi-level Positive Airway Pressure Devices), End User, and Region 2025-2033 |
2024年,全球正气道压力设备市场规模达38亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到61亿美元,2025-2033年期间的复合年增长率(CAGR)为5.14%。忧郁症、高血压、糖尿病和心臟病的发生率不断上升,刺激着市场的发展。
睡眠呼吸中止症盛行率不断上升
人们对睡眠障碍的认识不断提高,诊断和治疗的需求也随之增加,从而促进了市场的发展。例如,荷兰医疗保健公司飞利浦于2024年5月推出了用于治疗睡眠呼吸中止症的持续性正压呼吸器(CPAP)治疗设备。此外,在印度,飞利浦透过热线和网站提供支援。这为气道正压通气设备的市场前景做出了贡献。
不断进步的技术
持续的创新正在刺激市场发展,例如提升治疗效果、根据使用者需求自动调节压力水平、提升患者舒适度等。此外,面罩设计的进步,旨在最大限度地降低噪音,也推动了整体市场的发展。 2024年7月,先前以製氧机解决方案闻名的Varon推出了全新的Sunnygrand系列,该系列产品可与医生的处方设定和治疗方案相结合,为睡眠呼吸中止症患者提供有效舒适的治疗。它还支持医护人员的持续监测和调整。根据气道正压通气设备市场分析报告,这正成为重要的成长诱因。
家庭医疗保健需求不断增长
随着医疗成本的不断上涨以及以患者为中心的照护日益受到重视,越来越多的人选择居家管理睡眠呼吸中止症。这使得医疗保健提供者能够远端监控和调整治疗方案。 2024年3月,React Health 开发了一款名为 Luna TravelPAP 的旅行型 CPAP。它是一款小巧轻便的正压通气装置,具有 CPAP 和 AutoCPAP 模式。此外,它还具有供气提醒、可选便携包、指示灯等功能。
The global positive airway pressure devices market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.14% during 2025-2033. The increasing occurrence of depression, hypertension, diabetes, and heart disorders is stimulating the market.
Increasing Prevalence of Sleep Apnea
The rising awareness towards the occurrence of sleep disorders is escalating the demand for diagnosis and treatment, which is catalyzing the market. For example, in May 2024, Dutch healthcare company Philips launched continuous positive airway pressure (CPAP) therapy devices that are used to treat sleep apnea. Moreover, in India, Philips offered support through a hotline and website. This is contributing to the positive airway pressure devices market outlook.
Rising Technological Advancements
Continuous innovations, which enhance treatment efficacy, automatically adjust pressure levels based on the user's needs, elevate patient comfort, etc., are stimulating the market. Furthermore, advances in mask design with features aimed at minimizing noise are also propelling the overall market. In July 2024, Varon, previously known for oxygen concentrator solutions, introduced its new Sunnygrand series that offer effective and comfortable treatment for sleep apnea patients, integrating with doctors' prescribed settings and therapy plans. It also supports ongoing monitoring and adjustments by healthcare professionals. As per the positive airway pressure devices market analysis report, it is acting as a significant growth-inducing factor.
Escalating Demand for Home Healthcare
With the inflating healthcare costs and the increasing emphasis on patient-centric care, more individuals are opting for home-based management of sleep apnea. It allows healthcare providers to monitor and adjust treatment remotely. In March 2024, React Health developed a travel CPAP called the Luna TravelPAP. It is a small, lightweight positive airway pressure device with CPAP and AutoCPAP modes. Additionally, it has supply reminders, an optional carrying case, a light ring indicator, etc.
Continuous positive airway pressure (CPAP) devices dominate the total positive airway pressure devices market share
The inflating requirement for enhanced user comfort and treatment efficacy is driving the segment's growth. For example, the development of ResMed's AirSense 11, which features an auto-adjusting algorithm and integrated connectivity that enables personalized therapy adjustments and remote monitoring.
Hospitals and sleep labs hold the majority of the global positive airway pressure devices market demand
In these clinical settings, advanced PAP devices are utilized to ensure accurate diagnosis and effective treatment. For example, the Philips Respironics DreamStation BiPAP AutoSV is frequently adopted in hospitals for patients with complex sleep apnea, owing to its ability to adjust pressure levels automatically based on the patient's needs. This is expanding the positive airway pressure devices market forecast report.
North America exhibits a clear dominance in the market
The positive airway pressure devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The widespread prevalence of sleep apnea and other respiratory disorders is augmenting the positive airway pressure devices market outlook report in North America. In February 2024, ResMed introduced its AirCurve 11 series bilevel positive airway pressure devices in the U.S. It is designed to help providers treat sleep apnea while patients start and stay on therapy.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: